person · Reporting owner

Catapano Joseph Ronald

Disclosed activity across 2 companies

Tapewire entity: 1581
SEC CIK: 0001714468

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Teladoc Health, Inc.TDOC · Entity 1547	Chief Accounting Officer	October 01, 2026	October 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Teladoc Health, Inc.

Report date October 01, 2026 · Filed October 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	14,293	Ending reported balance After 2026-10-02 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-10-01 · Exercise / conversion · Acquired 2,083 · Balance 14,948 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-10-02 · Sale · Disposed 655 · Balance 14,293 F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	8,335	Reported balance After 2026-10-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-10-01 · Exercise / conversion · Disposed 2,083 · Balance 8,335 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

F3: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PITNEY BOWES INC /DE/

Report date September 06, 2024 · Filed September 10, 2024

Section 16 reporting ended · disclosed 2024-09-10. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	95,998	Ending reported balance After 2024-09-06 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2024-09-06 · Exercise / conversion · Acquired 11,881 · Balance 97,188 Row 2 · 2024-09-06 · Tax withholding · Disposed 3,783 · Balance 93,405 Row 3 · 2024-09-06 · Exercise / conversion · Acquired 3,805 · Balance 97,210 Row 4 · 2024-09-06 · Tax withholding · Disposed 1,212 · Balance 95,998
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2024-09-06 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2024-09-06 · Exercise / conversion · Disposed 11,881 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February.
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2024-09-06 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2024-09-06 · Exercise / conversion · Disposed 3,805 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February.
Common StockSEC Table I · non-derivative	Indirectby 401(k)	1,406	Reported balance Holding disclosure · report date 2024-09-06 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 1,406

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock.

F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 02, 2026 Filed Oct 5, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	655	$5.65	$3,702.72	Disclosure SEC source: 0001714468-26-000014 · wk-form4_1791230722.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,293 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	2,083	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000014 · wk-form4_1791230722.xml · derivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,335 Underlying: Common Stock · 2,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	2,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000014 · wk-form4_1791230722.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
September 02, 2026 Filed Sep 3, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	274	$6.30	$1,726.47	Disclosure SEC source: 0001714468-26-000012 · wk-form4_1788465936.xml · nonDerivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,865 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionPerformance Stock Units · Derivative	39	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000012 · wk-form4_1788465936.xml · derivative · entry 5 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232 Underlying: Common Stock · 39 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	833	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000012 · wk-form4_1788465936.xml · derivative · entry 4 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,001 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	39	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000012 · wk-form4_1788465936.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	833	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000012 · wk-form4_1788465936.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
July 02, 2026 Filed Jul 6, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	653	$9.10	$5,942.30	Disclosure SEC source: 0001714468-26-000010 · wk-form4_1783368313.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,267 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	2,083	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000010 · wk-form4_1783368313.xml · derivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,418 Underlying: Common Stock · 2,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis F3 · derivative.exercise_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	2,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000010 · wk-form4_1783368313.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document
June 02, 2026 Filed Jun 3, 2026 20:25 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	284	$7.63	$2,166.07	Disclosure SEC source: 0001714468-26-000008 · wk-form4_1780518300.xml · nonDerivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,837 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:25 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	833	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000008 · wk-form4_1780518300.xml · derivative · entry 5 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:25 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionPerformance Stock Units · Derivative	39	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000008 · wk-form4_1780518300.xml · derivative · entry 4 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271 Underlying: Common Stock · 39 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:25 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	833	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000008 · wk-form4_1780518300.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:25 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	39	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000008 · wk-form4_1780518300.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
April 02, 2026 Filed Apr 3, 2026 19:58 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	675	$5.11	$3,451.95	Disclosure SEC source: 0001714468-26-000006 · wk-form4_1775246305.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,249 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document
April 01, 2026 Filed Apr 3, 2026 19:58 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	2,083	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000006 · wk-form4_1775246305.xml · derivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,501 Underlying: Common Stock · 2,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
April 01, 2026 Filed Apr 3, 2026 19:58 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	2,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000006 · wk-form4_1775246305.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	1,333	$5.12	$6,820.96	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · nonDerivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,841 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	GrantRestricted Stock Units · Derivative	15,000	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · derivative · entry 7 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F8 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F9 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F9 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionPerformance Stock Units · Derivative	155	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · derivative · entry 6 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310 Underlying: Common Stock · 155 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	GrantPerformance Stock Units · Derivative	465	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · derivative · entry 5 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465 Underlying: Common Stock · 465 shares Expires not disclosed F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F6 · shares: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F6 · derivative.exercise_date: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F6 · derivative.expiration_date: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	3,333	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · derivative · entry 4 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	155	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:09 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	3,333	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000004 · wk-form4_1772572141.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
January 05, 2026 Filed Jan 6, 2026 21:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	758	$7.15	$5,415.91	Disclosure SEC source: 0001714468-26-000002 · wk-form4_1767733502.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,686 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	2,083	$0.00	$0.00	Disclosure SEC source: 0001714468-26-000002 · wk-form4_1767733502.xml · derivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,584 Underlying: Common Stock · 2,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	2,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-26-000002 · wk-form4_1767733502.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
October 02, 2025 Filed Oct 3, 2025 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	SaleCommon Stock	2,972	$7.89	$23,434.22	Disclosure SEC source: 0001714468-25-000007 · wk-form4_1759521909.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,361 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionRestricted Stock Units · Derivative	8,333	$0.00	$0.00	Disclosure SEC source: 0001714468-25-000007 · wk-form4_1759521909.xml · derivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 8,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:05 UTC	Teladoc Health, Inc. TDOC · Entity 1547	Exercise / conversionCommon Stock	8,333	Not disclosed	Not disclosed	Disclosure SEC source: 0001714468-25-000007 · wk-form4_1759521909.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:06 UTC	Teladoc Health, Inc. TDOC · Entity 1547	GrantRestricted Stock Units · Derivative	10,000	$0.00	$0.00	Disclosure SEC source: 0001477449-25-000019 · wk-form4_1741122398.xml · derivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
October 01, 2024 Filed Oct 4, 2024 20:08 UTC	Teladoc Health, Inc. TDOC · Entity 1547	GrantRestricted Stock Units · Derivative	25,000	$0.00	$0.00	Disclosure SEC source: 0001477449-24-000220 · wk-form4_1728072499.xml · derivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document
September 06, 2024 Filed Sep 10, 2024 19:58 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionRestricted Stock Unit · Derivative	3,805	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-24-006753 · primarydocument.xml · derivative · entry 7 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,805 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February. F2 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February. Read SEC document
September 06, 2024 Filed Sep 10, 2024 19:58 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionRestricted Stock Unit · Derivative	11,881	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001562180-24-006753 · primarydocument.xml · derivative · entry 6 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February. F2 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the fourth Tuesday in February. Read SEC document
September 06, 2024 Filed Sep 10, 2024 19:58 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Tax withholdingCommon Stock	1,212	$6.58	$7,974.96	Disclosure SEC source: 0001562180-24-006753 · primarydocument.xml · nonDerivative · entry 4 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,998 Read SEC document
September 06, 2024 Filed Sep 10, 2024 19:58 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionCommon Stock	3,805	$0.00	$0.00	Disclosure SEC source: 0001562180-24-006753 · primarydocument.xml · nonDerivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 06, 2024 Filed Sep 10, 2024 19:58 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Tax withholdingCommon Stock	3,783	$6.58	$24,892.14	Disclosure SEC source: 0001562180-24-006753 · primarydocument.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,405 Read SEC document
September 06, 2024 Filed Sep 10, 2024 19:58 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionCommon Stock	11,881	$0.00	$0.00	Disclosure SEC source: 0001562180-24-006753 · primarydocument.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 12, 2024 Filed Mar 14, 2024 20:14 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionRestricted Stock Units · Derivative	5,919	$0.00	$0.00	Disclosure SEC source: 0001562180-24-002674 · primarydocument.xml · derivative · entry 4 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,919 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: All awards listed in Table II above are subject to the terms of the Amended and Restated 2018 Stock Plan including applicable share limits. F2 · derivative.exercise_price: Each unit represents a contingent right to receive one share of Pitney Bowes common stock. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the second Tuesday in March. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the second Tuesday in March. Read SEC document
March 12, 2024 Filed Mar 14, 2024 20:14 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Tax withholdingCommon Stock	1,885	$4.09	$7,700.23	Disclosure SEC source: 0001562180-24-002674 · primarydocument.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,639 Read SEC document
March 12, 2024 Filed Mar 14, 2024 20:14 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionCommon Stock	5,919	$0.00	$0.00	Disclosure SEC source: 0001562180-24-002674 · primarydocument.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 27, 2024 Filed Feb 29, 2024 20:57 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionRestricted Stock Units · Derivative	1,903	$0.00	$0.00	Disclosure SEC source: 0001562180-24-001969 · primarydocument.xml · derivative · entry 7 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,805 Underlying: Common Stock · 1,903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: All awards listed in Table II above are subject to the terms of the 2018 Stock Plan including applicable share limits. F2 · derivative.exercise_price: Each unit represents a contingent right to receive one share of Pitney Bowes common stock. F4 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the Fourth Tuesday in February. F4 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the Fourth Tuesday in February. Read SEC document
February 27, 2024 Filed Feb 29, 2024 20:57 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionRestricted Stock Unit · Derivative	11,880	$0.00	$0.00	Disclosure SEC source: 0001562180-24-001969 · primarydocument.xml · derivative · entry 6 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,881 Underlying: Common Stock · 11,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: All awards listed in Table II above are subject to the terms of the 2018 Stock Plan including applicable share limits. F2 · derivative.exercise_price: Each unit represents a contingent right to receive one share of Pitney Bowes common stock. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the second Tuesday in March. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest over a three year period on the second Tuesday in March. Read SEC document
February 27, 2024 Filed Feb 29, 2024 20:57 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Tax withholdingCommon Stock	606	$0.00	$0.00	Disclosure SEC source: 0001562180-24-001969 · primarydocument.xml · nonDerivative · entry 4 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,605 Read SEC document
February 27, 2024 Filed Feb 29, 2024 20:57 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionCommon Stock	1,903	$0.00	$0.00	Disclosure SEC source: 0001562180-24-001969 · primarydocument.xml · nonDerivative · entry 3 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 27, 2024 Filed Feb 29, 2024 20:57 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Tax withholdingCommon Stock	3,783	$0.00	$0.00	Disclosure SEC source: 0001562180-24-001969 · primarydocument.xml · nonDerivative · entry 2 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,308 Read SEC document
February 27, 2024 Filed Feb 29, 2024 20:57 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	Exercise / conversionCommon Stock	11,880	$0.00	$0.00	Disclosure SEC source: 0001562180-24-001969 · primarydocument.xml · nonDerivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 15, 2024 Filed Feb 20, 2024 21:11 UTC	PITNEY BOWES INC /DE/ PBI · Entity 4392	GrantRestricted Stock Units · Derivative	12,531	$3.99	$49,998.69	Disclosure SEC source: 0001562180-24-001437 · primarydocument.xml · derivative · entry 1 Catapano Joseph Ronald · CIK 0001714468 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,919 Underlying: Common Stock · 12,531 shares Expires not disclosed F1 · security: All awards listed in Table II above are subject to the terms of the 2018 Stock Plan including applicable share limits. F2 · derivative.exercise_price: Each unit represents a contingent right to receive one share of Pitney Bowes common stock. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest pro rata annually over a three year period on the Fourth Tuesday in February. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will vest pro rata annually over a three year period on the Fourth Tuesday in February. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.